技术与方法 |
|
|
|
|
CHO细胞强化流加培养过程理性设计与建立 |
苏影1,张炜坚1,万宇翔2,沈天放2,张欣然1,张如悦1,谭文松1,3,赵亮1,3,*() |
1 华东理工大学生物反应器工程国家重点实验室 上海 200237 2 海正药业杭州有限公司 杭州 311404 3 上海倍谙基生物科技有限公司 上海 201203 |
|
Rational Design and Establishment of CHO Cell Intensified Fed-batch Culture Process |
SU Ying1,ZHANG Wei-jian1,WAN Yu-xiang2,SHEN Tian-fang2,ZHANG Xin-ran1,ZHANG Ru-yue1,TAN Wen-song1,3,ZHAO Liang1,3,*() |
1 State Key Laboratory of Bioreactor Engineering, East China University of Science and Technology, Shanghai 200237, China 2 Zhejiang Hisun Pharmaceutical Co., Ltd., Hangzhou 311404, China 3 Shanghai Bioengine Sci-Tech Co., Ltd., Shanghai 201203, China |
引用本文:
苏影, 张炜坚, 万宇翔, 沈天放, 张欣然, 张如悦, 谭文松, 赵亮. CHO细胞强化流加培养过程理性设计与建立[J]. 中国生物工程杂志, 2023, 43(10): 20-31.
SU Ying, ZHANG Wei-jian, WAN Yu-xiang, SHEN Tian-fang, ZHANG Xin-ran, ZHANG Ru-yue, TAN Wen-song, ZHAO Liang. Rational Design and Establishment of CHO Cell Intensified Fed-batch Culture Process. China Biotechnology, 2023, 43(10): 20-31.
链接本文:
https://manu60.magtech.com.cn/biotech/CN/10.13523/j.cb.2305046
或
https://manu60.magtech.com.cn/biotech/CN/Y2023/V43/I10/20
|
[1] |
O’Flaherty R, Bergin A, Flampouri E, et al. Mammalian cell culture for production of recombinant proteins: a review of the critical steps in their biomanufacturing. Biotechnology Advances, 2020, 43: 107552.
doi: 10.1016/j.biotechadv.2020.107552
|
[2] |
Fan Y Z, Ley D, Andersen M R. Fed-batch CHO cell culture for lab-scale antibody production. Methods in Molecular Biology, 2018, 1674: 147-161.
doi: 10.1007/978-1-4939-7312-5_12
pmid: 28921435
|
[3] |
Lin P C, Chan K F, Kiess I A, et al. Attenuated glutamine synthetase as a selection marker in CHO cells to efficiently isolate highly productive stable cells for the production of antibodies and other biologics. mAbs, 2019, 11(5): 965-976.
doi: 10.1080/19420862.2019.1612690
|
[4] |
Tang P F, Xu J L, Louey A, et al. Kinetic modeling of Chinese hamster ovary cell culture: factors and principles. Critical Reviews in Biotechnology, 2020, 40(2): 265-281.
doi: 10.1080/07388551.2019.1711015
pmid: 31928250
|
[5] |
Handlogten M W, Lee-O’Brien A, Roy G, et al. Intracellular response to process optimization and impact on productivity and product aggregates for a high-titer CHO cell process. Biotechnology and Bioengineering, 2018, 115(1): 126-138.
doi: 10.1002/bit.26460
pmid: 28941283
|
[6] |
Kelley B, Kiss R, Laird M. A different perspective: how much innovation is really needed for monoclonal antibody production using mammalian cell technology. Advances in Biochemical Engineering/Biotechnology, 2018, 165: 443-462.
|
[7] |
Stepper L, Filser F A, Fischer S, et al. Pre-stage perfusion and ultra-high seeding cell density in CHO fed-batch culture: a case study for process intensification guided by systems biotechnology. Bioprocess and Biosystems Engineering, 2020, 43(8): 1431-1443.
doi: 10.1007/s00449-020-02337-1
pmid: 32266469
|
[8] |
Schulze M, Kumar Y, Rattay M, et al. Transcriptomic analysis reveals mode of action of butyric acid supplementation in an intensified CHO cell fed-batch process. Biotechnology and Bioengineering, 2022, 119(9): 2359-2373.
doi: 10.1002/bit.v119.9
|
[9] |
Xu J L, Rehmann M S, Xu M M, et al. Development of an intensified fed-batch production platform with doubled titers using N-1 perfusion seed for cell culture manufacturing. Bioresources and Bioprocessing, 2020, 7(1): 17.
doi: 10.1186/s40643-020-00304-y
|
[10] |
Bielser J M, Wolf M, Souquet J, et al. Perfusion mammalian cell culture for recombinant protein manufacturing: a critical review. Biotechnology Advances, 2018, 36(4): 1328-1340.
doi: 10.1016/j.biotechadv.2018.04.011
|
[11] |
Xu S, Gavin J, Jiang R B, et al. Bioreactor productivity and media cost comparison for different intensified cell culture processes. Biotechnology Progress, 2017, 33(4): 867-878.
doi: 10.1002/btpr.2415
pmid: 27977910
|
[12] |
Jordan M, Mac Kinnon N, Monchois V, et al. Intensification of large-scale cell culture processes. Current Opinion in Chemical Engineering, 2018, 22: 253-257.
doi: 10.1016/j.coche.2018.11.008
|
[13] |
Yang W C, Lu J Y, Kwiatkowski C, et al. Perfusion seed cultures improve biopharmaceutical fed-batch production capacity and product quality. Biotechnology Progress, 2014, 30(3): 616-625.
doi: 10.1002/btpr.1884
pmid: 24574326
|
[14] |
Mahé A, Martiné A, Fagète S, et al. Exploring the limits of conventional small-scale CHO fed-batch for accelerated on demand monoclonal antibody production. Bioprocess and Biosystems Engineering, 2022, 45(2): 297-307.
doi: 10.1007/s00449-021-02657-w
|
[15] |
Pohlscheidt M, Jacobs M, Wolf S, et al. Optimizing capacity utilization by large scale 3000 L perfusion in seed train bioreactors. Biotechnology Progress, 2013, 29(1): 222-229.
doi: 10.1002/btpr.1672
pmid: 23225663
|
[16] |
Schulze M, Lemke J, Pollard D, et al. Automation of high CHO cell density seed intensification via online control of the cell specific perfusion rate and its impact on the N-stage inoculum quality. Journal of Biotechnology, 2021, 335: 65-75.
doi: 10.1016/j.jbiotec.2021.06.011
pmid: 34090946
|
[17] |
Brunner M, Kolb K, Keitel A, et al. Application of metabolic modeling for targeted optimization of high seeding density processes. Biotechnology and Bioengineering, 2021, 118(5): 1793-1804.
doi: 10.1002/bit.27693
pmid: 33491766
|
[18] |
Yongky A, Xu J L, Tian J, et al. Process intensification in fed-batch production bioreactors using non-perfusion seed cultures. mAbs, 2019, 11(8): 1502-1514.
doi: 10.1080/19420862.2019.1652075
pmid: 31379298
|
[19] |
Padawer I, Ling W L W, Bai Y L. Case study: an accelerated 8-day monoclonal antibody production process based on high seeding densities. Biotechnology Progress, 2013, 29(3): 829-832.
doi: 10.1002/btpr.1719
pmid: 23596148
|
[20] |
Bielser J M, Chappuis L, Xiao Y S, et al. Perfusion cell culture for the production of conjugated recombinant fusion proteins reduces clipping and quality heterogeneity compared to batch-mode processes. Journal of Biotechnology, 2019, 302: 26-31.
doi: 10.1016/j.jbiotec.2019.06.006
|
[21] |
Hecht V, Duvar S, Ziehr H, et al. Efficiency improvement of an antibody production process by increasing the inoculum density. Biotechnology Progress, 2014, 30(3): 607-615.
doi: 10.1002/btpr.1887
pmid: 24574274
|
[22] |
Pereira S, Kildegaard H F, Andersen M R. Impact of CHO metabolism on cell growth and protein production: an overview of toxic and inhibiting metabolites and nutrients. Biotechnology Journal, 2018, 13(3): e1700499.
|
[23] |
Ali A S, Raju R, Kshirsagar R, et al. Multi-omics study on the impact of cysteine feed level on cell viability and mAb production in a CHO bioprocess. Biotechnology Journal, 2019, 14(4): e1800352.
|
[24] |
范里. GS-CHO细胞无血清培养过程的开发与优化. 上海: 华东理工大学, 2010.
|
|
Fan L. Development and optimization of serum-free culture process of GS-CHO cells. Shanghai: East China University of Science and Technology, 2010.
|
[25] |
Bai Y L, Wu C J, Zhao J, et al. Role of iron and sodium citrate in animal protein-free CHO cell culture medium on cell growth and monoclonal antibody production. Biotechnology Progress, 2011, 27(1): 209-219.
doi: 10.1002/btpr.513
pmid: 21312368
|
[26] |
Parampalli A, Eskridge K, Smith L, et al. Developement of serum-free media in CHO-DG 44 cells using a central composite statistical design. Cytotechnology, 2007, 54(1): 57-68.
doi: 10.1007/s10616-007-9074-3
pmid: 19003018
|
[27] |
Ritacco F V, Wu Y Q, Khetan A. Cell culture media for recombinant protein expression in Chinese hamster ovary (CHO) cells: history, key components, and optimization strategies. Biotechnology Progress, 2018, 34(6): 1407-1426.
doi: 10.1002/btpr.2706
pmid: 30290072
|
[28] |
Zhang H F, Wang H B, Liu M, et al. Rational development of a serum-free medium and fed-batch process for a GS-CHO cell line expressing recombinant antibody. Cytotechnology, 2013, 65(3): 363-378.
doi: 10.1007/s10616-012-9488-4
pmid: 22907508
|
[29] |
Jordan M, Voisard D, Berthoud A, et al. Cell culture medium improvement by rigorous shuffling of components using media blending. Cytotechnology, 2013, 65(1): 31-40.
doi: 10.1007/s10616-012-9462-1
pmid: 22695856
|
[30] |
Liu Y Y, Zhang W Y, Deng X C, et al. Chinese hamster ovary cell performance enhanced by a rational divide-and-conquer strategy for chemically defined medium development. Journal of Bioscience and Bioengineering, 2015, 120(6): 690-696.
doi: 10.1016/j.jbiosc.2015.04.016
pmid: 26183860
|
[31] |
Kuwae S, Miyakawa I, Doi T. Development of a chemically defined platform fed-batch culture media for monoclonal antibody-producing CHO cell lines with optimized choline content. Cytotechnology, 2018, 70(3): 939-948.
doi: 10.1007/s10616-017-0185-1
pmid: 29322349
|
[32] |
Zhang J, Zhou J W, Liu J, et al. Development of chemically defined media supporting high cell density growth of Ketogulonicigenium vulgare and Bacillus megaterium. Bioresource Technology, 2011, 102(7): 4807-4814.
doi: 10.1016/j.biortech.2010.10.124
pmid: 21296571
|
|
Viewed |
|
|
|
Full text
|
|
|
|
|
Abstract
|
|
|
|
|
Cited |
|
|
|
|
|
Shared |
|
|
|
|
|
Discussed |
|
|
|
|